Departments
Home >> Departments >> Content

Hemotology

The Department of Hematology has been established for more than 40 years and has long undertaken clinical work, teaching, scientific research, health counseling, and follow-up of patients during rehabilitation for hematological diseases in the local area. It is currently a training site for master’s degree students in Internal Medicine at Shandong First Medical University. In 2009, it was rated by the Tai’an Municipal Health Bureau as one of the first batch of Medical Quality Demonstration Departments. In 2019, it was designated a Tai’an Municipal Clinical Key Specialty and successfully passed re-review in 2023.

The department has a professional technical team with high overall quality, a positive attitude, teamwork, and dedication. It currently has 15 physicians and 1 laboratory technician, including 4 chief physicians/professors, 5 associate chief physicians/associate professors, 4 master’s supervisors, and 14 holders of a Master of Medicine. There are 14 nursing staff in the ward, including 2 nurse-in-charge, 6 senior nurses, and 4 nurses. Medical and nursing staff always adhere to the service tenet of “Quality First, Patients Supreme.” They are dedicated to their work and are patient, meticulous, and responsible toward patients. They frequently carry out various health education activities, reflecting good service, good quality, and good medical ethics in all respects, and are widely praised by patients.

The successive directors—from the renowned provincial professor Zheng Yuanlong to the former Directors of the Department of Internal Medicine Professor Gao Xiang and Professor Zhou Li, and then to the current academic leader Professor Zhang Zhirong—have done extensive work in department construction, echelon planning, talent training, and the introduction of new technologies. The department has always attached importance to improving staff professional competence and has a strong academic atmosphere. It attends the National Hematology Conference every year and has sent staff many times to study at nationally renowned hematology diagnosis and treatment centers such as Shanghai Ruijin Hospital, Tianjin Institute of Hematology, Peking University First Hospital, Peking University People’s Hospital, Anhui Provincial People’s Hospital, and Qilu Hospital, promptly applying advanced diagnostic and treatment technologies in clinical practice. It has successively carried out idarubicin treatment for acute myeloid leukemia; BTK inhibitors and rituximab for chronic lymphocytic leukemia and B-cell lymphoma; imatinib and other tyrosine kinase inhibitors for chronic myeloid leukemia; bortezomib and pomalidomide combined with CD38 monoclonal antibody for multiple myeloma; high-dose intravenous immunoglobulin pulse therapy combined with CD20 monoclonal antibody, eltrombopag, low-dose decitabine, etc., for severe immune thrombocytopenia; and ATG combined with cyclosporine and other drugs for severe aplastic anemia. It has also gradually carried out autologous hematopoietic stem cell transplantation for multiple myeloma, poor-prognosis malignant lymphoma, and other diseases, achieving significant efficacy. In recent years, individualized treatment plans have been explored according to patients’ conditions, making chemotherapy regimens and corticosteroid use more standardized and rational. For severe infections, antibiotic de-escalation therapy is adopted; for fungal infections, greater attention is paid to early preemptive antifungal therapy; and for severe adverse effects of intensive chemotherapy, early prediction, formulation of rescue plans, and implementation one by one are carried out. The department has accumulated rich experience in the treatment of critically ill hematological patients and has successfully treated many critically ill patients with hemophagocytic syndrome, severe fever with thrombocytopenia syndrome, profound agranulocytosis, extreme thrombocytopenia, severe infection, etc. It has won the hospital-level award for successful rescue of critically ill patients for 10 consecutive years.

The department has comprehensive technical strength and an independent hematology laboratory, offering bone marrow cytology, bone marrow histochemical staining, and hemolytic anemia-related tests. In cooperation with Guangzhou KingMed Diagnostics, it carries out cell immunomarker, chromosome, and fusion gene testing, enabling the diagnosis and efficacy evaluation of hematological diseases to meet international standards and be more accurate and comprehensive.

For many years, the Department of Hematology has undertaken teaching tasks in Hematologic Diseases in Internal Medicine and Diagnostics for postgraduate and undergraduate students at Shandong First Medical University, and has actively carried out clinical research. In recent years, it has undertaken more than 10 provincial research projects and more than 10 university-level projects, published 8 books, and published more than 30 papers in national and provincial journals.

Tel: 0538-6233076 (Doctor’s Office)
0538-6237419 (Nurse Station)
0538-6237417 (Outpatient Clinic)
150-6417-7120 (Hematology Follow-up Telephone)